Skip to main content Accessibility help
×
Hostname: page-component-77c89778f8-rkxrd Total loading time: 0 Render date: 2024-07-17T00:35:05.288Z Has data issue: false hasContentIssue false

5 - Therapeutic decision making in BMT/SCT for chronic lymphatic leukemia

Published online by Cambridge University Press:  31 July 2009

Reinhold Munker
Affiliation:
Louisiana State University
Hillard M. Lazarus
Affiliation:
University Hospitals Case Medical Center
Kerry Atkinson
Affiliation:
University of Queensland
Get access
Type
Chapter
Information
The BMT Data Book , pp. 71 - 84
Publisher: Cambridge University Press
Print publication year: 2009

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Binet, JL, Auquier, A, Dighiero, G, et al. 1981. A new prognostic classification of chronic lymphocytic leukemia derived from a multivariate survival analysis. Cancer 48: 198–206.3.0.CO;2-V>CrossRefGoogle ScholarPubMed
Binet, JL, Caligaris-Cappio, F, Catovsky, D, et al. 2006. Perspective on the use of new diagnostic tools in the treatment of chronic lymphocytic leukemia. Blood 107: 859–61.CrossRefGoogle Scholar
Brown, JR, Kim, HT, Li, S, et al. 2006. Predictors of improved progression-free survival after non-myeloablative allogeneic stem cell transplantation for advanced chronic lymphocytic leukemia. Biol Blood Marrow Transpl 12: 1056–64.CrossRefGoogle Scholar
Byrd, JC, Rai, K, Peterson, BL, et al., 2005. Addition of rituximab to fludarabine may prolong progression-free survival and overall survival in patients with previously untreated chronic lymphocytic leukemia. Blood 105: 49–53.CrossRefGoogle ScholarPubMed
Calin, GA, Pekarsky, Y, and Croce, CM. 2007. The role of microRNA and other non-coding RNA in the pathogenesis of chronic lymphocytic leukemia. Best Practice Res Clin Haematol 20: 425–37.CrossRefGoogle ScholarPubMed
Catovsky, D, Richards, S, Matutes, E, et al. 2007. Assessment of fludarabine plus cyclophosphamide for patients with chronic lymphocytic leukemia (the LRF CLL4 trial): a randomized controlled trial. Lancet 370: 230–39.CrossRefGoogle Scholar
Del Principe, ML, Del Poeta, G, Buiccisano, F, et al. 2006. Clinical significance of ZAP-70 protein expression in B-cell chronic lymphocytic leukemia. Blood 108: 853–61.CrossRefGoogle ScholarPubMed
Döhner, H, Stilgenbauer, S, Benner, A, et al. 2000. Genomic aberrations and survival in chronic lymphocytic leukemia. N Engl J Med 343: 1910–18.CrossRefGoogle ScholarPubMed
Dreger, P, Corradini, P, Kimby, E, et al. 2007 Indications for stem cell transplantation in chronic lymphocytic leukemia: The EBMT transplant consensus. Leukemia 21: 12–17.CrossRefGoogle ScholarPubMed
Gribben, JG, Zahrieh, D, Stephans, K, et al. 2005 Autologous and allogeneic stem cell transplantations for poor-risk chronic lymphocytic leukemia. Blood 106: 4389–96.CrossRefGoogle ScholarPubMed
Jantunen, E, Itälä, M, Siitonen, T, et al. 2006. Autologous stem cell transplantation in patients with chronic lymphocytic leukaemia: The Finnish experience. Bone Marr Transpl 37: 1093–98.CrossRefGoogle ScholarPubMed
Keating, MJ, Flinn, I, Jain, V. 2002. Therapeutic role of alemtuzumab (Campath-1H) in patients who have failed fludarabine. Blood 99: 3554–61.CrossRefGoogle ScholarPubMed
Michallet, M, Archimbaud, E, Bandini, G et al. 1996 HLA-identical sibling bone marrow transplantation in younger patients with chronic lymphocytic leukemia. Ann Int Med 124: 311–15.CrossRefGoogle ScholarPubMed
Rai, KR, Sawitsky, A, Cronkite, EP, et al. 1975. Clinical staging of chronic lymphocytic leukemia. Blood 46: 219–34.Google ScholarPubMed
Rai, KR and Han, T. 1990. Prognostic factors and clinical staging in chronic lymphocytic leukemiaHem/Onc Clin NA 4: 447–51.Google ScholarPubMed
Sorror, ML, Maris, MB, Sandmaier, BM, et al. 2005. Hematopoietic cell transplantation after nonmyeloablative conditioning for advanced chronic lymphocytic leukemia. J Clin Oncol 23: 3819–29.CrossRefGoogle ScholarPubMed
Weiss, MA, Maslak, PG, Jurcic, JG, et al. 2003. Pentostatin and cyclophosphamide: an effective new regimen in previously treated patients with chronic lymphocytic leukemia. J Clin Oncol 21: 1278–84.CrossRefGoogle ScholarPubMed
Wright, SJ, Robertson, , O'Brien, S, et al. 1994. The role of fludarabine in haematological malignancies. Blood Reviews 8: 125–34.CrossRefGoogle Scholar

Save book to Kindle

To save this book to your Kindle, first ensure [email protected] is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×